Skip to main content
Log in

Isolation of vancomycin-resistant enterococci in haematologic patients

  • Notes
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

After the occurrence of septicaemia with a vancomycin-resistantEnterococcus faecalis strain in a patient, it was decided to determine the number of carriers of vancomycin-resistant cocci among haematologic patients. During a period of six months 135 stool samples from 25 children, and 400 samples from 70 adults were studied. All samples from the children were negative for vancomycin-resistant cocci. Nine of the adult patients had cultures positive for cocci, all identified as enterococci, which were highly resistant to vancomycin (MIC>250µg/ml), sensitive to amoxicillin, moderately resistant to gentamicin, slightly resistant to teicoplanin, and sensitive to daptomycin. None of these patients had been given vancomycin prior to the isolation of the vancomycin-resistant enterococci.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Guiot HFL, Van Furth R Infection prevention by modulation of the host flora. In: Jackson GG, Schlumberger HD, Zeiler HJ (ed): Perspectives in antiinfective therapy. Springer Verlag, Berlin, 1989, p. 285–294.

    Google Scholar 

  2. Pizzo PA, Ladisch S, Simons RM Increasing incidence of gram-positive sepsis in cancer patients. Medical and Pediatric Oncology 1978, 5: 241–244.

    PubMed  Google Scholar 

  3. Pizzo PA, Ladisch S, Witebsky FG Alpha-haemolytic streptococci: clinical significance in the cancer patient. Medical and Pediatric Oncology 1978, 4: 367–370.

    PubMed  Google Scholar 

  4. Rozenberg-Arska M, Dekker A, Verdonck L, Verhoef J Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin. Infection 1989, 17: 240–244.

    PubMed  Google Scholar 

  5. Peters WG, Willemze R, Colly LP, Guiot HFL Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. Netherlands Journal of Medicine 1987, 30: 64–74.

    PubMed  Google Scholar 

  6. Guiot HFL, Peters WG, van den Broek PJ, van der Meer JWM, Kramps JA, Willemze R, van Furth R Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 1990, 18: 131–137.

    PubMed  Google Scholar 

  7. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J High level vancomycin-resistant enterococci causing hospital infections. Epidemiological Infection 1989, 103: 173–181.

    Google Scholar 

  8. Nicas TI, Wu CYE, Hobbs JN, Preston DA, Allen NE Characterization of vancomycin resistance inEnterococcus faecium andEnterococcus faecalis. Antimicrobial Agents and Chemotherapy 1989, 33: 1121–1124.

    PubMed  Google Scholar 

  9. Leclerq R, Derlot E, Weber M, Duval J, Courvalin P Transferable vancomycin and teicoplanin resistance inEnterococcus faecium. Antimicrobial Agents and Chemotherapy 1989, 33: 10–15.

    PubMed  Google Scholar 

  10. Shlaes, DM, Bouvet A, Devine C, Shlaes JH, Al-Obeid S, Williamson R Inducible, transferable resistance to vancomycin inEnterococcus faecalis A256. Antimicrobial Agents and Chemotherapy 1989, 33: 198–203.

    PubMed  Google Scholar 

  11. Shlaes, DM, Al-Obeid S, Shlaes JH, Boivison A, Williamson R Inducible, transferable resistance to vancomycin inEnterococcus faecium D399. Journal of Antimicrobial Chemotherapy 1989, 23: 503–508.

    PubMed  Google Scholar 

  12. Guiot HFL, van den Broek PJ, van der Meer JWM, van Furth R Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukaemia: a double-blind, placebo-controlled study. Journal of Infectious Diseases 1983, 147: 615–623.

    PubMed  Google Scholar 

  13. Guiot HFL, Helmig-Schurter AV, van der Meer JWM, van Furth R Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures. Scandinavian Journal of Infectious Diseases 1986, 18: 153–160.

    PubMed  Google Scholar 

  14. Fertally SS, Facklam R Comparison of physiologic tests used to identify non-beta-hemolytic aerococci, enterococci, and streptococci. Journal of Clinical Microbiology 1987, 22: 1845–1850.

    Google Scholar 

  15. Facklam R, Hollis D, Collins MD Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria. Journal of Clinical Microbiology 1989, 27: 724–730.

    PubMed  Google Scholar 

  16. De La Maza L, Ruoff KL, Ferraro MJ In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1989, 33: 1383–1384.

    PubMed  Google Scholar 

  17. Greenwood D Microbiological properties of teicoplanin. Journal of Antimicrobial Chemotherapy 1988, 21, Supplement A: 1–13.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guiot, H.F.L., Peetermans, W.E. & Sebens, F.W. Isolation of vancomycin-resistant enterococci in haematologic patients. Eur. J. Clin. Microbiol. Infect. Dis. 10, 32–34 (1991). https://doi.org/10.1007/BF01967094

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967094

Keywords

Navigation